Cetuximab Becomes First Drug Approved for Head and Neck Cancer in 30 Years
Waun Ki Hong: Cetuximab Becomes First Drug Approved for Head and Neck Cancer in 30 Years
20080801
2008 Sept 1
OncologySTAT One-Year Anniversary Special
Cetuximab Becomes First Drug Approved for Head and Neck Cancer in 30 Years
OncologySTAT One-Year Anniversary Special. 2008 Sept 1
The integration of anti-EGFR monoclonal antibodies into advanced head and neck cancer treatment is an important milestone.
Meet Our Experts
Meet our Advisory and Editorial Boards comprised of physician editors and world-renowned experts.
